BioNTech suffers huge losses as vaccine demand falls

BioNTech suffers huge losses  German drugmaker BioNTech has suffered a huge loss in 2024 due to a drop in global demand for its Covid-19 vaccine. According to a company report released on Monday, their loss in the past year was 665.3 million euros (about $721 million). Despite earning a profit of more than 930 million euros in 2023, BioNTech failed to make a profit in any financial year for the first time since 2019 due to the company’s huge loss in 2024. According to the report, the company’s revenue in…

Read More